PRCT — Procept Biorobotics Income Statement
0.000.00%
- $3.14bn
- $2.97bn
- $136.19m
- 31
- 11
- 84
- 37
Annual income statement for Procept Biorobotics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 6.17 | 7.72 | 34.5 | 75 | 136 |
Cost of Revenue | |||||
Gross Profit | -1.89 | -1.25 | 15.9 | 37.1 | 71 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 49.7 | 55.5 | 88.6 | 159 | 245 |
Operating Profit | -43.5 | -47.8 | -54.2 | -84 | -109 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -42 | -53 | -59.9 | -87.2 | -106 |
Net Income After Taxes | -42 | -53 | -59.9 | -87.2 | -106 |
Net Income Before Extraordinary Items | |||||
Net Income | -42 | -53 | -59.9 | -87.2 | -106 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -42 | -53 | -59.9 | -87.2 | -106 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.993 | -1.25 | -1.37 | -1.89 | -2.24 |